Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CDR1 Biologics Sequence Review Report 2026: Cerebellar degeneration-related antigen 1 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CDR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD99L2 Biologics Sequence Review Report 2026: CD99 antigen-like protein 2 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD99L2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD9 Biologics Sequence Review Report 2026: CD9 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD9 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD8B2 Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD8 beta-2 chain Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD8B2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD83 Biologics Sequence Review Report 2026: CD83 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD83 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD82 Biologics Sequence Review Report 2026: CD82 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD82 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD81 Biologics Sequence Review Report 2026: CD81 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD81 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD74 Biologics Sequence Review Report 2026: HLA class II histocompatibility antigen gamma chain Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD74 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD72 Biologics Sequence Review Report 2026: B-cell differentiation antigen CD72 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD72 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD63 Biologics Sequence Review Report 2026: CD63 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD63 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD5L Biologics Sequence Review Report 2026: CD5 antigen-like Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD5L protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD58 Biologics Sequence Review Report 2026: Lymphocyte function-associated antigen 3 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD58 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
257
258
259
260
261
>>
1670
>